Cx Institutional Abiomed Inc Transaction History

Cx Institutional

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$224.73 - $338.64 $10,562 - $15,916	47 New	47 $12,000
Q4 2021 Jan 18, 2022	SELL	$300.63 - $371.35 $27,357 - $33,792	-91 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $4,032 - $4,890	13 Added 16.67%	91 $30,000
Q2 2021 Aug 04, 2021	BUY	$262.71 - $351.17 $8,932 - $11,939	34 Added 77.27%	78 $24,000
Q1 2021 Apr 15, 2021	BUY	$285.92 - $355.13 $2,001 - $2,485	7 Added 18.92%	44 $14,000
Q4 2020 Jan 12, 2021	BUY	$251.88 - $324.2 $4,030 - $5,187	16 Added 76.19%	37 $12,000
Q3 2020 Oct 13, 2020	SELL	$255.22 - $317.0 $255 - $317	-1 Reduced 4.55%	21 $6,000
Q2 2020 Aug 06, 2020	BUY	$141.4 - $257.09 $3,110 - $5,655	22 New	22 $5,000
Q4 2019 Jan 21, 2020	SELL	$159.31 - $223.54 $1,115 - $1,564	-7 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$175.89 - $279.23 $1,231 - $1,954	7 New	7 $1,000
Q1 2019 Apr 03, 2019	SELL	$276.39 - $362.25 $552 - $724	-2 Closed	0 $0
Q4 2018 Jan 14, 2019	BUY	$281.08 - $444.25 $562 - $888	2 New	2 $1,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.